Hodgkin Lymphoma Treatment Market Report

China Hodgkin Lymphoma Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Aug 20, 2023
  • PAGES：219
  • REPORT CODE：GMM1746760
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Hodgkin Lymphoma Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Incyte Corporation

    • Cellular Biomedicine Group, Inc

    • Gilead Sciences, Inc

    • Merck & Co, Inc

    • NantKwest, Inc

    • Curis, Inc

    • Molecular Templates Inc

    • Mirati Therapeutics Inc

    • Gamida Cell Ltd

    • Faron Pharmaceuticals Oy

    • Cell Medica Limited

    By Type:

    • Azacitidine

    • Alocrest

    • Others

    • ANK Program

    • BPX-501

    • BMS-986016

    By Application:

    • Research Center

    • Hospital

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Hodgkin Lymphoma Treatment Market Overview 2018-2029

    • 1.1 China Hodgkin Lymphoma Treatment Industry Development Overview

    • 1.2 China Hodgkin Lymphoma Treatment Industry Development History

    • 1.3 China Hodgkin Lymphoma Treatment Industry Market Size (2018-2029)

    • 1.4 China Hodgkin Lymphoma Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of Azacitidine (2018-2029)

      • 1.4.2 China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of Alocrest (2018-2029)

      • 1.4.3 China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of ANK Program (2018-2029)

      • 1.4.5 China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of BPX-501 (2018-2029)

      • 1.4.6 China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of BMS-986016 (2018-2029)

    • 1.5 China Hodgkin Lymphoma Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Hodgkin Lymphoma Treatment Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)

      • 1.5.2 China Hodgkin Lymphoma Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Hodgkin Lymphoma Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China Hodgkin Lymphoma Treatment Market Analysis by Region

      • 1.6.1 North China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Hodgkin Lymphoma Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Hodgkin Lymphoma Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Hodgkin Lymphoma Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Hodgkin Lymphoma Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Hodgkin Lymphoma Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Hodgkin Lymphoma Treatment Industry Development

    Chapter 3 Hodgkin Lymphoma TreatmentIndustry Chain Analysis

    • 3.1 Hodgkin Lymphoma Treatment Industry Chain

    • 3.2 Hodgkin Lymphoma Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Hodgkin Lymphoma Treatment Market

    • 3.3 Hodgkin Lymphoma Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Hodgkin Lymphoma Treatment Market

    Chapter 4 China Hodgkin Lymphoma Treatment Market, by Type

    • 4.1 China Hodgkin Lymphoma Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Hodgkin Lymphoma Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Hodgkin Lymphoma Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of Azacitidine

      • 4.5.2 China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of Alocrest

      • 4.5.3 China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of Others

      • 4.5.4 China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of ANK Program

      • 4.5.5 China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of BPX-501

      • 4.5.6 China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of BMS-986016

    Chapter 5 China Hodgkin Lymphoma Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Hodgkin Lymphoma Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Hodgkin Lymphoma Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Hodgkin Lymphoma Treatment Market Size and Growth Rate of Research Center

      • 5.5.2 China Hodgkin Lymphoma Treatment Market Size and Growth Rate of Hospital

      • 5.5.3 China Hodgkin Lymphoma Treatment Market Size and Growth Rate of Clinic

    Chapter 6 China Hodgkin Lymphoma Treatment Market, by Region

    • 6.1 China Hodgkin Lymphoma Treatment Production Volume and Production Value, by Region

    • 6.2 China Hodgkin Lymphoma Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Hodgkin Lymphoma Treatment Market Analysis

    • 7.1 North China Hodgkin Lymphoma Treatment Market, by Type

    • 7.2 North China Hodgkin Lymphoma Treatment Market, by Application

    Chapter 8 Central China Hodgkin Lymphoma Treatment Market Analysis

    • 8.1 Central China Hodgkin Lymphoma Treatment Market, by Type

    • 8.2 Central China Hodgkin Lymphoma Treatment Market, by Application

    Chapter 9 South China Hodgkin Lymphoma Treatment Market Analysis

    • 9.1 South China Hodgkin Lymphoma Treatment Market, by Type

    • 9.2 South China Hodgkin Lymphoma Treatment Market, by Application

    Chapter 10 East China Hodgkin Lymphoma Treatment Market Analysis

    • 10.1 East China Hodgkin Lymphoma Treatment Market, by Type

    • 10.2 East China Hodgkin Lymphoma Treatment Market, by Application

    Chapter 11 Northeast China Hodgkin Lymphoma Treatment Market Analysis

    • 11.1 Northeast China Hodgkin Lymphoma Treatment Market, by Type

    • 11.2 Northeast China Hodgkin Lymphoma Treatment Market, by Application

    Chapter 12 Southwest China Hodgkin Lymphoma Treatment Market Analysis

    • 12.1 Southwest China Hodgkin Lymphoma Treatment Market, by Type

    • 12.2 Southwest China Hodgkin Lymphoma Treatment Market, by Application

    Chapter 13 Northwest China Hodgkin Lymphoma Treatment Market Analysis

    • 13.1 Northwest China Hodgkin Lymphoma Treatment Market, by Type

    • 13.2 Northwest China Hodgkin Lymphoma Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Incyte Corporation

        • 14.1.1 Incyte Corporation Company Profile

        • 14.1.2 Incyte Corporation Hodgkin Lymphoma Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Cellular Biomedicine Group, Inc

        • 14.2.1 Cellular Biomedicine Group, Inc Company Profile

        • 14.2.2 Cellular Biomedicine Group, Inc Hodgkin Lymphoma Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Gilead Sciences, Inc

        • 14.3.1 Gilead Sciences, Inc Company Profile

        • 14.3.2 Gilead Sciences, Inc Hodgkin Lymphoma Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Merck & Co, Inc

        • 14.4.1 Merck & Co, Inc Company Profile

        • 14.4.2 Merck & Co, Inc Hodgkin Lymphoma Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 NantKwest, Inc

        • 14.5.1 NantKwest, Inc Company Profile

        • 14.5.2 NantKwest, Inc Hodgkin Lymphoma Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Curis, Inc

        • 14.6.1 Curis, Inc Company Profile

        • 14.6.2 Curis, Inc Hodgkin Lymphoma Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Molecular Templates Inc

        • 14.7.1 Molecular Templates Inc Company Profile

        • 14.7.2 Molecular Templates Inc Hodgkin Lymphoma Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Mirati Therapeutics Inc

        • 14.8.1 Mirati Therapeutics Inc Company Profile

        • 14.8.2 Mirati Therapeutics Inc Hodgkin Lymphoma Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Gamida Cell Ltd

        • 14.9.1 Gamida Cell Ltd Company Profile

        • 14.9.2 Gamida Cell Ltd Hodgkin Lymphoma Treatment Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Faron Pharmaceuticals Oy

        • 14.10.1 Faron Pharmaceuticals Oy Company Profile

        • 14.10.2 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Cell Medica Limited

        • 14.11.1 Cell Medica Limited Company Profile

        • 14.11.2 Cell Medica Limited Hodgkin Lymphoma Treatment Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Hodgkin Lymphoma Treatment Industry Research Conclusions

    • 15.2 Hodgkin Lymphoma Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Hodgkin Lymphoma Treatment Industry Market Size (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of Azacitidine (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of Alocrest (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of ANK Program (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of BPX-501 (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Production Volume, Production Value and Growth Rate of BMS-986016 (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Sales Volume, Sales Value and Growth Rate of Research Center (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Hodgkin Lymphoma Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Hodgkin Lymphoma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Hodgkin Lymphoma Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Hodgkin Lymphoma Treatment Market Share by Type in 2018

    • Figure China Hodgkin Lymphoma Treatment Market Share by Type in 2023

    • Figure China Hodgkin Lymphoma Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of Azacitidine (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of Alocrest (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of ANK Program (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of BPX-501 (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Production Volume and Growth Rate of BMS-986016 (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Market Share by Application in 2018

    • Figure China Hodgkin Lymphoma Treatment Market Share by Application in 2023

    • Figure China Hodgkin Lymphoma Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Hodgkin Lymphoma Treatment Market Size and Growth Rate of Research Center (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Market Size and Growth Rate of Clinic (2018-2023)

    • Table China Hodgkin Lymphoma Treatment Production Volume by Region (2018-2023)

    • Table China Hodgkin Lymphoma Treatment Production Volume Share by Region (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Production Volume Share by Region (2018-2023)

    • Table China Hodgkin Lymphoma Treatment Production Value by Region (2018-2023)

    • Table China Hodgkin Lymphoma Treatment Production Value Share by Region (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Production Value Share by Region (2018-2023)

    • Table China Hodgkin Lymphoma Treatment Sales Volume by Region (2018-2023)

    • Table China Hodgkin Lymphoma Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Sales Volume Share by Region (2018-2023)

    • Table China Hodgkin Lymphoma Treatment Sales Value by Region (2018-2023)

    • Table China Hodgkin Lymphoma Treatment Sales Value Share by Region (2018-2023)

    • Figure China Hodgkin Lymphoma Treatment Sales Value Share by Region (2018-2023)

    • Table North China Hodgkin Lymphoma Treatment Production Volume by Type (2018-2023)

    • Table North China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Table North China Hodgkin Lymphoma Treatment Sales Volume by Application (2018-2023)

    • Table North China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Hodgkin Lymphoma Treatment Production Volume by Type (2018-2023)

    • Table Central China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Hodgkin Lymphoma Treatment Sales Volume by Application (2018-2023)

    • Table Central China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Hodgkin Lymphoma Treatment Production Volume by Type (2018-2023)

    • Table South China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Table South China Hodgkin Lymphoma Treatment Sales Volume by Application (2018-2023)

    • Table South China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Hodgkin Lymphoma Treatment Production Volume by Type (2018-2023)

    • Table East China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Table East China Hodgkin Lymphoma Treatment Sales Volume by Application (2018-2023)

    • Table East China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Hodgkin Lymphoma Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Hodgkin Lymphoma Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Hodgkin Lymphoma Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Hodgkin Lymphoma Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Hodgkin Lymphoma Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Hodgkin Lymphoma Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Hodgkin Lymphoma Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Hodgkin Lymphoma Treatment Sales Volume Share by Application (2018-2023)

    • Table Incyte Corporation Company Profile

    • Table Incyte Corporation Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Cellular Biomedicine Group, Inc Company Profile

    • Table Cellular Biomedicine Group, Inc Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences, Inc Company Profile

    • Table Gilead Sciences, Inc Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table NantKwest, Inc Company Profile

    • Table NantKwest, Inc Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Curis, Inc Company Profile

    • Table Curis, Inc Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Molecular Templates Inc Company Profile

    • Table Molecular Templates Inc Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Mirati Therapeutics Inc Company Profile

    • Table Mirati Therapeutics Inc Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Gamida Cell Ltd Company Profile

    • Table Gamida Cell Ltd Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Faron Pharmaceuticals Oy Company Profile

    • Table Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)

    • Table Cell Medica Limited Company Profile

    • Table Cell Medica Limited Hodgkin Lymphoma Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US